drugset / Trial / NCT00199940

Safety And Efficacy Study Of Ziprasidone In Pediatric Psychotic Illness

NCT00199940

Phase 4 Completed 20 enrolled Medical College of Wisconsin
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this research is to determine if Ziprasidone is safe and effective for use in children and adolescents with a psychotic illness, and to determine of Ziprasidone treatment leads to weight changes in children.

Timeline

Start
2003-12
Primary completion
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Ziprasidone Small molecule